Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma

Journal of Clinical Oncology

Volumn 24, Issue 34, 2006, Pages 5427-5433

  Brown, Paul D ^a   Jensen, Ashley W ^a   Felten, Sara J ^a   Ballman, Karla V ^a   Schaefer, Paul L ^a   Jaeckle, Kurt A ^a   Cerhan, Jane H ^a   Buckner, Jan C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE;

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CLINICAL TRIAL; COGNITIVE DEFECT; EVIDENCE BASED MEDICINE; FEMALE; GLIOMA; HUMAN; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; ASTROCYTOMA; BRAIN TUMOR; CLASSIFICATION; DISEASE COURSE; GLIOSARCOMA; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL RATE;

ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; GLIOMA; GLIOSARCOMA; HUMANS; MALE; MIDDLE AGED; SURVIVAL RATE;

EID: 34247195502     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.08.5605     Document Type: Article

References (40)

1. Walker MD, Alexander E Jr, Hunt WE, et al: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: A cooperative clinical trial. J Neurosurg 49:333-343, 1978
2. Kristiansen K, Hagen S, Kollevold T, et al: Combined modality therapy of operated astrocytomas grade III and IV: Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time - A prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47:649-652, 1981
3. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005
4. DeAngelis LM, Delattre JY, Posner JB: Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789-796, 1989
5. Surma-aho O, Niemela M, Vilkki J, et al: Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology 56:1285-1290, 2001
6. Crossen JR, Garwood D, Glatstein E, et al: Neurobehavioral sequelae of cranial irradiation in adults: A review of radiation-induced encephalopathy. J Clin Oncol 12:627-642, 1994
7. Sneed PK, Suh JH, Goetsch SJ, et al: A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53:519-526, 2002
8. Regine WF, Huhn JL, Patchell RA, et al: Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: Results and implications. Int J Radiat Oncol Biol Phys 52:333-338, 2002 [Erratum: Int J Radiat Oncol Biol Phys 53:259, 2002]
9. Patchell RA, Tibbs PA, Regine WF, et al: Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial. JAMA 280:1485-1489, 1998
10. Meyers CA, Smith JA, Bezjak A, et al: Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: Results of a randomized phase III trial. J Clin Oncol 22:157-165, 2004
11. Klein M, Heimans JJ, Aaronson NK, et al: Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: A comparative study. Lancet 360:1361-1368, 2002
12. Torres IJ, Mundt AJ, Sweeney PJ, et al: A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors. Neurology 60:1113-1118, 2003
13. Taylor BV, Buckner JC, Cascino TL, et al: Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. J Clin Oncol 16:2195-2201, 1998
14. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State:" A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198, 1975
15. Dinapoli RP, Brown LD, Arusell RM, et al: Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma. J Clin Oncol 11:1316-1321, 1993
16. Rao RD, Thome SD, O'Fallon J, et al: Safety of thrice-daily hyperfractionated radiation and BCNU for high-grade gliomas. Int J Radiat Oncol Biol Phys 53:376-384, 2002
17. Rajkumar SV, Buckner JC, Schomberg PJ, et al: Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma. Int J Radiat Oncol Biol Phys 40:297-302, 1998
18. Buckner JC, Schomberg PJ, McGinnis WL, et al: A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma. Cancer 92:420-433, 2001
19. Rajkumar SV, Buckner JC, Schomberg PJ, et al: Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas. Neurosurgery 44:67-73, 1999
20. Rajkumar SV, Buckner JC, Schomberg PJ, et al: Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma. Int J Radiat Oncol Biol Phys 42:969-975, 1998
21. Buckner JC, Michalak JC, Schomberg PJ, et al: Phase III trial of BCNU plus cisplatin versus BCNU alone and standard radiation therapy versus accelerated radiation therapy in glioblastoma patients. Proc Am Soc Clin Oncol 51a, 2001 (abstr 202)
22. Tombaugh TN, McIntyre NJ: The Mini-Mental State Examination: A comprehensive review. J Am Geriatr Soc 40:922-935, 1992
23. Salmon DP, Thal LJ, Butters N, et al: Longitudinal evaluation of dementia of the Alzheimer type: A comparison of 3 standardized mental status examinations. Neurology 40:1225-1230, 1990
24. Galasko D, Klauber MR, Hofstetter CR, et al: The Mini-Mental State Examination in the early diagnosis of Alzheimer's disease. Arch Neurol 47:49-52, 1990
25. Tangalos EG, Smith GE, Ivnik RJ, et al: The Mini-Mental State Examination in general medical practice: Clinical utility and acceptance. Mayo Clin Proc 71:829-837, 1996
26. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
27. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
28. Archibald YM, Lunn D, Ruttan LA, et al: Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg 80:247-253, 1994
29. Laack NN, Brown PD: Cognitive sequelae of brain radiation in adults. Semin Oncol 31:702-713, 2004
30. Kleinberg L, Wallner K, Malkin MG: Good performance status of long-term disease-free survivors of intracranial gliomas. Int J Radiat Oncol Biol Phys 26:129-133, 1993 [Erratum: Int J Radiat Oncol Biol Phys 26:563, 1993]
31. Gregor A, Cull A, Traynor E, et al: Neuropsychometric evaluation of long-term survivors of adult brain tumours: Relationship with tumour and treatment parameters. Radiother Oncol 41:55-59, 1996
32. Curnes JT, Laster DW, Ball MR, et al: MRI of radiation injury to the brain. AJR Am J Roentgenol 147:119-124, 1986
33. Scheibel RS, Meyers CA, Levin VA: Cognitive dysfunction following surgery for intracerebral glioma: Influence of histopathology, lesion location, and treatment. J Neurooncol 30:61-69, 1996
34. Imperato JP, Paleologos NA, Vick NA: Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol 28:818-822, 1990
35. Klein M, Taphoorn MJ, Heimans JJ, et al: Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol 19:4037-4047, 2001
36. Bosma I, Vos M, Heimans JJ, et al: The course of neurocognitive status in high-grade glioma patients. Neuro-oncol 7:336, 2005
37. Maire JP, Coudin B, Guerin J, et al: Neuropsychologic impairment in adults with brain tumors. Am J Clin Oncol 10:156-162, 1987
38. Brown PD, Buckner JC, O'Fallon JR, et al: Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein Mini-Mental State Examination. J Clin Oncol 21:2519-2524, 2003
39. Meyers CA, Hess KR: Multifaceted end points in brain tumor clinical trials: Cognitive deterioration precedes MRI progression. Neuro-oncol 5:89-95, 2003
40. Armstrong CL, Hunter JV, Ledakis GE, et al: Late cognitive and radiographic changes related to radiotherapy: Initial prospective findings. Neurology 59:40-48, 2002